封面
市场调查报告书
商品编码
1843742

2025年全球医疗保健人工智慧市场报告

Artificial Intelligence in Healthcare Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,人工智慧在医疗保健领域的市场规模呈指数级增长,从2024年的181.6亿美元增长到2025年的241亿美元,复合年增长率达32.7%。这一增长可归因于合作与伙伴关係的增加、慢性病患病率的上升、人工智慧在放射学领域的应用日益广泛、人工智慧在经济高效的药物研发中的应用日益广泛,以及医疗保健领域人工智慧资金筹措的不断增加。

预计未来几年,医疗保健领域的人工智慧市场将呈指数级增长,到2029年市场规模将达到720.3亿美元,复合年增长率(CAGR)为31.5%。预测期内的成长可归因于老年人口的成长、医疗保健领域数位转型的年复合成长率以及政府措施。预测期内的关键趋势包括:人工智慧在临床试验中的应用、人工智慧在罕见疾病治疗中的应用、人工智慧在药物依从性方面的应用、人工智慧在标靶选择中的应用、人工智慧模型在临床前试验中的应用、对人工智慧主导生物技术公司的投资、併购活动的增加、合约研究组织(CRO)在人工智慧生态系统中日益重要的作用、人工智慧生态系统中日益重要的作用、

医疗保健领域的人工智慧是指利用机器学习和认知演算法来改善治疗和患者疗效,并应用于各种医疗保健领域,包括医学诊断、药物发现、临床试验、疼痛管理和患者整体改善。

医疗保健领域的人工智慧产品主要包括硬体和软体。这些产品运用多种演算法,包括深度学习、查询方法、自然语言处理和上下文感知处理。医疗设备製造商正利用人工智慧技术创新其硬体产品,以辅助医疗服务提供者并提升治疗效果。科技公司则专注于开发适用于医疗保健解决方案的人工智慧演算法。人工智慧在医疗保健领域的应用范围广泛,包括机器人辅助手术、虚拟护理助理、行政工作流程支援、诈欺检测、减少用药错误、临床试验参与者识别和初步诊断。人工智慧在医疗保健领域的主要用户包括医院、诊断中心、製药和生物製药公司、医疗保险机构以及个人患者。

美国在2025年春季突然提高关税及其引发的贸易摩擦,对资讯科技产业,特别是硬体製造、资料基础设施和软体部署领域,产生了重大影响。进口半导体、电路基板和网路设备的关税上涨,推高了高科技公司、云端服务供应商和资料中心的生产和营运成本。在全球范围内采购笔记型电脑、伺服器和消费电子产品零件的公司,面临更长的前置作业时间和价格压力。同时,对专用软体征收的关税以及主要国际市场的报復性措施,扰乱了全球IT供应链,并降低了海外对美国製造技术的需求。为了应对这些挑战,该产业正在加大对国内晶片生产的投资,扩大供应商网络,并利用人工智慧驱动的自动化技术来增强韧性,更有效地控製成本。

本研究报告是商业研究公司(The Business Research Company)最新系列报告的一部分,该系列报告提供有关医疗保健领域人工智能的市场统计数据,包括全球市场规模、区域份额、医疗保健领域人工智能市场份额的竞争对手、详细的医疗保健领域人工智能市场细分、市场趋势和商业机会,为您提供在医疗保健领域人工智能行业取得成功所需的数据。这份医疗保健领域人工智慧市场研究报告对该行业的现状和未来发展趋势进行了详细分析,为您提供全面的观点,满足您的所有需求。

未来五年31.5%的成长预测较我们先前对该市场的预测略微下调了0.3%。这一下调主要归因于美国与其他国家之间的关税影响。由于从德国和日本主要供应商采购的诊断硬体和软体系统需缴纳关税,医疗服务提供者在采用人工智慧方面可能会遇到延误。此外,由于相互关税措施以及贸易紧张局势和限制升级对全球经济和贸易造成的负面影响,这种影响也将更加广泛。

精准医疗的日益普及是推动人工智慧融入医疗保健市场的主要动力。精准医疗利用个体的基因资讯以及环境和生活方式因素,为患者量身定制诊断和治疗方案。它在肿瘤学领域尤其普遍,随着癌症发生率的上升,精准医疗领域对人工智慧的需求预计将会增加。例如,总部位于美国的非营利组织「个人化医疗联盟」(Personalized Medicine Coalition)在2024年2月报告称,美国食品药物管理局(FDA)在2023年核准了16种针对罕见疾病患者的个人化治疗方案,高于2022年的6种。因此,精准医疗的广泛应用正在推动人工智慧医疗保健市场的成长。

各国政府加强对医疗保健领域人工智慧的支持倡议,预计将推动人工智慧医疗保健市场的成长。印度和中国等国已推出多项旨在加强人工智慧在医疗保健领域应用的倡议。例如,2022年4月,印度政府专注于利用人工智慧监测全国范围内的疾病爆发。目前,印度政府正与国家疾病管制中心(NCDC)合作开发一款工具,该工具将扫描与健康相关的媒体通报,建立资料库,追踪综合疾病监测计画(IDSP)下监测的33种疾病,其中一些疾病可能具有流行潜力。此外,2022年9月,美国国立卫生研究院(NIH)——一家专注于医学研究的联邦机构——推出了Bridge2AI计划,将在四年内投资1.3亿美元,以促进人工智慧在生物医学和行为科学领域的应用。该倡议,预计将推动市场成长。

医疗保健人工智慧 (AI) 市场的参与者正在密切关注创新 AI 工具的应用,这些工具将为製药公司带来显着效益。一些知名公司正在策略性地将新型 AI 工具引入药物研发领域。领先企业内部的科学研究团队正积极开发新型工具,以协助全球新冠肺炎治疗药物的研发。例如,Aster DM 医疗集团的创新中心 Aster 创新与研究中心于 2022 年 7 月与英特尔公司和 AI 平台供应商 CARPL.ai 合作,在印度建立了一个 AI 驱动的健康数据平台。

製药和生物製药公司正积极收购在资料科学和人工智慧领域拥有专长的公司。这种策略性措施旨在透过增强决策流程、优化研究和临床试验效率,以及为包括医生、消费者、保险公司和监管机构在内的利害关係人相关人员,来推动医疗保健产业的创新。 2022年1月,固定门诊影像服务供应商RadNet收购了放射学人工智慧公司Aidence,该公司专注于为肺结节管理和肺癌筛检提供人工智慧临床解决方案。 2022年2月,领先的远距皮肤科服务供应商OnlineDoctor收购了德国新创新兴企业ASSIST(Automated Scientific Skin Infection Search Technology),该公司在皮肤病学人工智慧领域拥有丰富的经验,从而扩展了自身的服务能力。 OnlineDoctor是欧洲领先的远距皮肤病学服务供应商,与皮肤科医生、药局、医院和健康保险公司合作,并在瑞士、德国和奥地利设有办公室。

2024年9月,美国医疗科技公司史赛克(Stryker Corporation)宣布将收购care.ai,具体金额未揭露。此次收购旨在透过将先进的人工智慧辅助虚拟医疗解决方案融入史赛克的产品和服务,强化其数位化医疗策略。史赛克希望透过增强其在智慧病房技术和环境智慧的专业能力,改善即时决策工具,从而更好地支持医疗服务提供者并改善患者的治疗效果。 care.ai是一家总部位于美国的科技公司,专注于人工智慧主导的医疗解决方案。

在医疗保健人工智慧市场中营运的主要公司包括:IBM Watson Health、Nuance Communications, Inc、Alphabet Inc、Concreto HealthAI、Nvidia Corporation、PathAI、XtalPi、Benevolent AI、Exscientia、OWKIN、LiveHealth、ChironX、Consure Medicalem、Predible Health、Lybrate、Artelus、Oncodem Qure.ai、嘉兴泰美医疗科技股份有限公司、平安健康医疗科技股份有限公司、依图医疗、iCarbonX、Insilico、Skin Analytics、Babylon Health、Cambridge Cognition、Renalytix AI、Iktos、诺华、Gero、Ardigen、Botkin、Webiomed、Medutor AI、Diagnocat、Atomise、Enagno、Atomc​​yia、Aconc​​hi​​oo 你) Pharmaceuticals、Verge Genomics、Berg LLC、Deep Genomics、Cyclica、IQVIA、罗氏、辉瑞、PRA Healthscience、Gesto、Intensicare。 Discience、Betterfly、Deenty、Examedi、Dentalink、Cero、MedPass、Pixeon、Hi Technologies、Conexa Saude、Wuru、Yerbo、Bioscience、Caecus、Epitrack、GE Healthcare、Oncora Medical、Recursion Pharmaceuticals Inc、Nucle、Pepticom、AstraiY、Rt.

2024年,北美是医疗保健领域人工智慧市场最大的区域。预计亚太地区将在预测期内成为成长最快的区域。这份医疗保健领域人工智慧市场报告涵盖亚太地区、西欧、中东欧、北美、南美以及中东和非洲。

医疗保健人工智慧市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大。

医疗保健领域的人工智慧市场包括营业单位透过发现基因密码之间的关联、驱动手术机器人以及提高医院效率而获得的收入。市场价值包括服务供应商销售的或包含在服务产品中的相关商品的价值。它仅包括营业单位之间交易或出售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税,以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球医疗保健领域的人工智慧:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 终端用户产业分析
  • 全球医疗保健人工智慧市场:成长率分析
  • 全球医疗保健人工智慧市场表现:规模与成长,2019-2024年
  • 全球医疗保健人工智慧市场预测:规模和成长,2024-2029年,2034年
  • 医疗保健领域的人工智慧:全球潜在市场规模 (TAM)

第六章 市场细分

  • 全球医疗保健人工智慧市场:依产品、效能和预测划分,2019-2024年、2024-2029年、2034年
  • 硬体
  • 软体
  • 服务
  • 全球医疗保健领域人工智慧市场:依演算法、效能和预测划分,2019-2024年、2024-2029年、2034年
  • 深度学习
  • 查询方法
  • 自然语言处理
  • 情境感知处理
  • 全球医疗保健领域人工智慧市场:按应用、效能和预测划分,2019-2024年、2024-2029年、2034年
  • 机器人辅助手术
  • 虚拟护理助理
  • 管理工作流程支持
  • 诈欺侦测
  • 减少剂量误差
  • 临床试验参与者识别符
  • 初步诊断
  • 全球医疗保健人工智慧市场按最终用户、效能和预测划分,2019-2024年、2024-2029年、2034年
  • 医院和诊断中心
  • 製药和生物製药公司
  • 医疗保健支付方
  • 病人
  • 全球医疗保健人工智慧市场:按硬体(类型)、效能和预测进行细分,2019-2024年、2024-2029年、2034年
  • 人工智慧成像设备
  • 穿戴式健康监测设备
  • 机器人和手术设备
  • 全球医疗保健人工智慧市场:按软体类型、效能和预测细分,2019-2024年、2024-2029年、2034年
  • 诊断软体
  • 预测分析软体
  • 自然语言处理(NLP)软体
  • 全球医疗保健人工智慧市场:按服务类型、效能和预测细分,2019-2024年、2024-2029年、2034年
  • 咨询服务
  • 实施服务
  • 维护和支援服务

第七章 区域和国家分析

  • 全球医疗保健人工智慧市场:区域表现与预测,2019-2024年、2024-2029年、2034年
  • 全球医疗保健人工智慧市场:国家、表现与预测,2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第十八章:法国市场

第十九章:义大利市场

第二十章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第三十章:竞争格局与公司概况

  • 人工智慧在医疗保健领域的应用:竞争格局
  • 医疗保健领域的人工智慧市场:公司概况
    • IBM Watson Health Overview, Products and Services, Strategy and Financial Analysis
    • Nuance Communications, Inc Overview, Products and Services, Strategy and Financial Analysis
    • Alphabet Inc Overview, Products and Services, Strategy and Financial Analysis
    • Concreto HealthAI Overview, Products and Services, Strategy and Financial Analysis
    • Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • PathAI
  • XtalPi
  • Benevolent AI
  • Exscientia
  • OWKIN
  • LiveHealth
  • ChironX
  • Consure Medical
  • Predible Health
  • Lybrate
  • Artelus
  • OncoStem Qure.ai
  • Jiaxing Taimei Medical Technology
  • Ping An Health Medical Technology
  • YITU

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章:高潜力市场国家、细分市场与策略

  • 2029年医疗保健领域人工智慧市场:提供新机会的国家
  • 2029年医疗保健领域的人工智慧:充满新机会的细分市场
  • 2029 年医疗保健领域的人工智慧:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r25465u

AI in healthcare denotes the utilization of machine learning and cognitive algorithms to enhance treatment methods and patient outcomes. It finds application across various healthcare facets such as medical diagnostics, drug discovery, clinical trials, pain management, and overall patient improvement.

AI in healthcare offerings primarily comprises hardware and software. Within these offerings, AI products leverage diverse algorithms including deep learning, querying methods, natural language processing, and context-aware processing. Medical device manufacturers harness AI-based technologies to innovate hardware products, aiding healthcare providers and enhancing treatments. Technology firms focus on developing AI algorithms tailored for healthcare solutions. The applications of AI in healthcare are widespread, encompassing robot-assisted surgery, virtual nursing aides, support in administrative workflows, fraud detection, dosage error reduction, identification of clinical trial participants, and preliminary diagnoses. Key users of AI in healthcare span hospitals, diagnostic centers, pharmaceutical and biopharmaceutical companies, healthcare payers, and individual patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The Artificial Intelligence in healthcare market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in healthcare market statistics, including artificial intelligence in healthcare industry global market size, regional shares, competitors with artificial intelligence in healthcare market share, detailed artificial intelligence in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare industry. This artificial intelligence in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in healthcare market size has grown exponentially in recent years. It will grow from $18.16 billion in 2024 to $24.1 billion in 2025 at a compound annual growth rate (CAGR) of 32.7%. The growth in the historic period can be attributed to growing number of collaborations and partnerships, rising prevalence of chronic diseases, increasing implementation of AI in radiology, the growing adoption of artificial intelligence for cost-efficient drug discovery, and rising funding in artificial intelligence in healthcare.

The artificial intelligence in healthcare market size is expected to see exponential growth in the next few years. It will grow to $72.03 billion in 2029 at a compound annual growth rate (CAGR) of 31.5%. The growth in the forecast period can be attributed to an increase in the geriatric population, the growing adoption of digital transformation in healthcare, and increasing government initiatives for supporting artificial intelligence in healthcare. Major trends in the forecast period include the use of AI for clinical trials, AI for rare diseases treatment, AI for drug adherence, AI in target selection, leveraging AI-based models in pre-clinical studies, investments in AI-driven biotech firms, rise in merger and acquisition activity, the emerging role of CROs in AI ecosystems, the introduction of new artificial intelligence (AI) tools, the introduction of AI innovation labs.

The forecast of 31.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Healthcare providers may see delays in AI adoption due to tariffs on diagnostic hardware and software systems sourced from leading suppliers in Germany and Japan. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing adoption of precision medicine is a key driving factor for the integration of artificial intelligence in the healthcare market. Precision medicine utilizes information about an individual's genetics, along with environmental and lifestyle factors, to tailor diagnoses and therapies for patients. It is particularly prevalent in oncology, and as the incidence of cancer rises, the demand for AI in precision medicine is expected to increase. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six in 2022. Consequently, the rise in precision medicine adoption is propelling growth in the artificial intelligence healthcare market.

The rise in government initiatives to support artificial intelligence in healthcare is anticipated to drive growth in the AI healthcare market. Countries like India and China are launching various initiatives aimed at enhancing AI applications in healthcare. For example, in April 2022, the Indian government focused on leveraging AI to monitor disease outbreaks across the country. A tool currently being developed in collaboration with the National Centre for Disease Control (NCDC) will scan health-related media reports to create a database tracking 33 diseases monitored under the Integrated Disease Surveillance Programme (IDSP), some of which have epidemic potential. Additionally, in September 2022, the National Institutes of Health (NIH), a U.S.-based federal agency dedicated to medical research, introduced the Bridge2AI program, investing $130 million over four years to advance the use of AI in biomedical and behavioral research. This initiative aims to create ethically sourced, AI-ready datasets and standards by bringing together diverse research teams. Therefore, the increase in government initiatives supporting artificial intelligence in healthcare is expected to promote market growth.

Entities within the artificial intelligence (AI) for the healthcare market are observing the introduction of innovative AI tools with significant benefits for pharmaceutical companies. Prominent corporations are strategically launching new AI-enabled tools in the drug discovery sector. Scientific communities within major enterprises are diligently developing novel tools to contribute to the global efforts in COVID-19 treatment development. In a notable example, the Aster Innovation and Research Centre, the innovation hub of the Aster DM Healthcare Group, collaborated with Intel Corporation and AI platform provider CARPL.ai in July 2022 to create an AI-powered health data platform in India.

Pharmaceutical and biopharmaceutical companies are actively pursuing acquisitions of firms possessing expertise in data science and AI. This strategic approach aims to drive innovation within the healthcare industry by enhancing decision-making processes, optimizing research and clinical trials efficiency, and creating valuable tools for stakeholders such as physicians, consumers, insurers, and regulators. In January 2022, RadNet, a provider of fixed-site outpatient diagnostic imaging services, acquired Aidence, a radiology AI company specializing in AI-enabled clinical solutions for pulmonary nodule management and lung cancer screening. In February 2022, OnlineDoctor, a leading teledermatology provider, expanded its capabilities by acquiring A.S.S.I.S.T (Automated Scientific Skin Infection Search Technology), a German startup with expertise in AI for dermatology. OnlineDoctor operates as one of Europe's premier teledermatology providers, with a presence in Switzerland, Germany, and Austria, collaborating with dermatologists, pharmacies, hospitals, and health insurance companies.

In September 2024, Stryker Corporation, a U.S.-based medical technology firm, announced its acquisition of care.ai for an undisclosed sum. This acquisition is intended to strengthen Stryker's digital healthcare strategy by incorporating advanced AI-assisted virtual care solutions into its offerings. By enhancing its expertise in smart room technology and ambient intelligence, Stryker aims to improve real-time decision-making tools that assist healthcare providers and enhance patient care outcomes. Care.ai is a U.S.-based company that specializes in artificial intelligence-driven healthcare solutions.

Major companies operating in the artificial intelligence in healthcare market include IBM Watson Health, Nuance Communications, Inc, Alphabet Inc, Concreto HealthAI, Nvidia Corporation, PathAI, XtalPi, Benevolent AI, Exscientia, OWKIN, LiveHealth, ChironX, Consure Medical, Predible Health, Lybrate, Artelus, OncoStem Qure.ai, Jiaxing Taimei Medical Technology, Ping An Health Medical Technology, YITU, iCarbonX, Insilico, Skin Analytics, Babylon Health, Cambridge Cognition, Renalytix AI, Iktos, Novartis, Gero, Ardigen, Botkin, Webiomed, Care Mentor AI, Diagnocat, Atomwise Inc, Cloud Pharmaceuticals, Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica, IQVIA, Roche, Pfizer, PRA Healthscience, Gesto, Intensicare, Didoc, Betterfly, Deenty, Examedi, Dentalink, Cero, MedPass, Pixeon, Hi Technologies, Conexa Saude, Wuru, Yerbo, BioScience, Caecus, Epitrack, GE Healthcare, Oncora Medical, Recursion Pharmaceuticals Inc, Nucleai, Pepticom, AstraZeneca, Rology, HearX Group, DilenyTech, iNNOHEALTH Technology Solutions

North America was the largest region in the Artificial Intelligence in the Healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The AI in healthcare market includes revenues earned by entities by discovering links between genetic codes, powering surgical robots and maximizing hospital efficiency. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence in Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Offering: Hardware, Software, Services
  • 2) By Algorithm: Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing
  • 3) By Application: Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis
  • 4) By End-User: Hospitals And Diagnostic Centers, Pharmaceutical And Biopharmaceutical Companies, Healthcare Payers, Patients
  • Subsegments:
  • 1) By Hardware: AI-Powered Imaging Devices; Wearable Health Monitoring Devices; Robotics And Surgical Devices
  • 2) By Software: Diagnostic Software; Predictive Analytics Software; Natural Language Processing (NLP) Software
  • 3) By Services: Consulting Services; Implementation Services; Maintenance And Support Services
  • Companies Mentioned: IBM Watson Health; Nuance Communications, Inc; Alphabet Inc; Concreto HealthAI; Nvidia Corporation; PathAI; XtalPi; Benevolent AI; Exscientia; OWKIN; LiveHealth; ChironX; Consure Medical; Predible Health; Lybrate; Artelus; OncoStem Qure.ai; Jiaxing Taimei Medical Technology; Ping An Health Medical Technology; YITU; iCarbonX; Insilico; Skin Analytics; Babylon Health; Cambridge Cognition; Renalytix AI; Iktos; Novartis; Gero; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; Atomwise Inc; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Deep Genomics; Cyclica; IQVIA; Roche; Pfizer; PRA Healthscience; Gesto; Intensicare; Didoc; Betterfly; Deenty; Examedi; Dentalink; Cero; MedPass; Pixeon; Hi Technologies; Conexa Saude; Wuru; Yerbo; BioScience; Caecus; Epitrack; GE Healthcare; Oncora Medical; Recursion Pharmaceuticals Inc; Nucleai; Pepticom; AstraZeneca; Rology; HearX Group; DilenyTech; iNNOHEALTH Technology Solutions
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence in Healthcare Market Characteristics

3. Artificial Intelligence in Healthcare Market Trends And Strategies

4. Artificial Intelligence in Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence in Healthcare Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence in Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence in Healthcare Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence in Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence in Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence in Healthcare Total Addressable Market (TAM)

6. Artificial Intelligence in Healthcare Market Segmentation

  • 6.1. Global Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hardware
  • Software
  • Services
  • 6.2. Global Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Learning
  • Querying Method
  • Natural Language Processing
  • Context Aware Processing
  • 6.3. Global Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Robot-Assisted Surgery
  • Virtual Nursing Assistant
  • Administrative Workflow Assistance
  • Fraud Detection
  • Dosage Error Reduction
  • Clinical Trial Participant Identifier
  • Preliminary Diagnosis
  • 6.4. Global Artificial Intelligence in Healthcare Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Centers
  • Pharmaceutical And Biopharmaceutical Companies
  • Healthcare Payers
  • Patients
  • 6.5. Global Artificial Intelligence in Healthcare Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI-Powered Imaging Devices
  • Wearable Health Monitoring Devices
  • Robotics And Surgical Devices
  • 6.6. Global Artificial Intelligence in Healthcare Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Software
  • Predictive Analytics Software
  • Natural Language Processing (NLP) Software
  • 6.7. Global Artificial Intelligence in Healthcare Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation Services
  • Maintenance And Support Services

7. Artificial Intelligence in Healthcare Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence in Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence in Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence in Healthcare Market

  • 8.1. Asia-Pacific Artificial Intelligence in Healthcare Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence in Healthcare Market

  • 9.1. China Artificial Intelligence in Healthcare Market Overview
  • 9.2. China Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence in Healthcare Market

  • 10.1. India Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence in Healthcare Market

  • 11.1. Japan Artificial Intelligence in Healthcare Market Overview
  • 11.2. Japan Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence in Healthcare Market

  • 12.1. Australia Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence in Healthcare Market

  • 13.1. Indonesia Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence in Healthcare Market

  • 14.1. South Korea Artificial Intelligence in Healthcare Market Overview
  • 14.2. South Korea Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence in Healthcare Market

  • 15.1. Western Europe Artificial Intelligence in Healthcare Market Overview
  • 15.2. Western Europe Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence in Healthcare Market

  • 16.1. UK Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence in Healthcare Market

  • 17.1. Germany Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence in Healthcare Market

  • 18.1. France Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence in Healthcare Market

  • 19.1. Italy Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence in Healthcare Market

  • 20.1. Spain Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence in Healthcare Market

  • 21.1. Eastern Europe Artificial Intelligence in Healthcare Market Overview
  • 21.2. Eastern Europe Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence in Healthcare Market

  • 22.1. Russia Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence in Healthcare Market

  • 23.1. North America Artificial Intelligence in Healthcare Market Overview
  • 23.2. North America Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence in Healthcare Market

  • 24.1. USA Artificial Intelligence in Healthcare Market Overview
  • 24.2. USA Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence in Healthcare Market

  • 25.1. Canada Artificial Intelligence in Healthcare Market Overview
  • 25.2. Canada Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence in Healthcare Market

  • 26.1. South America Artificial Intelligence in Healthcare Market Overview
  • 26.2. South America Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence in Healthcare Market

  • 27.1. Brazil Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence in Healthcare Market

  • 28.1. Middle East Artificial Intelligence in Healthcare Market Overview
  • 28.2. Middle East Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence in Healthcare Market

  • 29.1. Africa Artificial Intelligence in Healthcare Market Overview
  • 29.2. Africa Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence in Healthcare Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence in Healthcare Market Competitive Landscape
  • 30.2. Artificial Intelligence in Healthcare Market Company Profiles
    • 30.2.1. IBM Watson Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Nuance Communications, Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alphabet Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Concreto HealthAI Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence in Healthcare Market Other Major And Innovative Companies

  • 31.1. PathAI
  • 31.2. XtalPi
  • 31.3. Benevolent AI
  • 31.4. Exscientia
  • 31.5. OWKIN
  • 31.6. LiveHealth
  • 31.7. ChironX
  • 31.8. Consure Medical
  • 31.9. Predible Health
  • 31.10. Lybrate
  • 31.11. Artelus
  • 31.12. OncoStem Qure.ai
  • 31.13. Jiaxing Taimei Medical Technology
  • 31.14. Ping An Health Medical Technology
  • 31.15. YITU

32. Global Artificial Intelligence in Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence in Healthcare Market

34. Recent Developments In The Artificial Intelligence in Healthcare Market

35. Artificial Intelligence in Healthcare Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence in Healthcare Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence in Healthcare Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence in Healthcare Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer